← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Socratech, Llc
Rochester, NY
$1,720,419
Total funding
7
Grants
Funding over time
peak $618.8K · FY2006–10$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,720,419 · 7
By mechanism
R42$1,084,494 · 1
R43$414,000 · 4
R41$221,925 · 2
Investigators at Socratech, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
SRF/MYOCD: new targets in Alzheimer's neurovasculature$586,365
R42 · FY2009 · AG
SRF/MYOCD: new targets in Alzheimer's neurovasculature$498,129
R42 · FY2008 · AG
Recombinant LRP fragments production for Alzheimer?s disease treatment$120,636
R41 · FY2008 · AG
Target Assessment in Alzheimer's Neurovasculature/BBB$107,000
R43 · FY2004 · AG
CNS Cellular Senescence/Targeting Endothelial SIPS$107,000
R43 · FY2004 · AG
SRF/MYOCD: new targets in Alzheimer's neurovasculature$101,289
R41 · FY2006 · AG
Enhance Production of Functional Recombinant Human Protein C Variant In Mammalian$100,000
R43 · FY2010 · NS
Small Arteries as a Therapeutic Target in AD$100,000
R43 · FY2004 · AG